Actively Recruiting
Phase 12a Study of ALN-PNP Safety and Effects in Healthy Adults and Adults with MASLD Evaluating Single and Multiple Doses in Adults Aged 18 to 75
Led by Regeneron Pharmaceuticals · Updated on 2026-04-16
172
Participants Needed
6
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying an experimental drug called ALN-PNP in healthy adults and adults with Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD who have a specific PNPLA3 gene variant. This first-in-human trial aims to evaluate the safety, tolerability, and how the drug is processed in the body across three parts Part A with healthy participants, and Parts B and C with MASLD participants. The study also explores the drugs impact on liver fat and potential side effects related to the drug. The study involves randomized, double-blind treatment with ALN-PNP or placebo given in single and multiple doses. Part A includes healthy adults aged 18 to 55, including a cohort of Japanese participants, while Parts B and C include adults with MASLD aged up to 65 and 75 respectively. Participants receive the study drug according to protocol and are monitored for drug levels, immune response, and changes in liver fat and blood lipids over time. Participants will be involved in safety assessments including monitoring treatment-emergent adverse events up to day 337 and measuring liver fat by MRI-PDFF up to day 253. Blood samples will be taken to check drug concentration, metabolites, and antibodies. Lipid profiles and other biomarkers will be tracked through the study. The trial includes thorough follow-up over several months to assess safety, drug effects, and tolerability in detail.
CONDITIONS
Brief Title
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Research Team
C
Clinical Trials Administrator
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here